慢性稳定期高碳酸血症性慢阻肺的长期无创通气:ATS临床实践指南
美国胸科学会(ATS)针对慢性稳定期高碳酸血症性慢阻肺患者长期无创通气(NIV)的临床应用制定指南,基于GRADE方法对五个PICO问题给出条件性推荐。建议在常规治疗基础上加用夜间NIV、启动前筛查阻塞性睡眠呼吸暂停、不在急性加重住院期间启动长期NIV、不用实验室多导睡眠图滴定NIV,并建议以PaCO2目标正常化为滴定目标。
要点
- 慢性稳定期高碳酸血症性慢阻肺患者可在常规治疗基础上加用夜间NIV。
- 启动长期NIV前应筛查阻塞性睡眠呼吸暂停。
- 不在急性加重住院期间启动长期NIV,建议稳定后2-4周再评估。
核心结论
- 专家组基于证据对慢性稳定期高碳酸血症性慢阻肺患者长期NIV的五个临床问题给出条件性推荐。
研究设计与样本
- 遵循GRADE方法总结五个PICO问题的证据,由呼吸与睡眠医师、呼吸治疗师和方法学家组成专家组使用Evidence-to-Decision框架制定推荐。
主要发现
- 建议在常规治疗基础上加用夜间NIV(条件性推荐,中等确定性)。
- 建议启动长期NIV前筛查阻塞性睡眠呼吸暂停(条件性推荐,极低确定性)。
- 建议不在急性加重住院期间启动长期NIV,而是在缓解后2-4周重新评估(条件性推荐,低确定性)。
- 建议不用实验室过夜多导睡眠图滴定NIV(条件性推荐,极低确定性)。
- 建议长期NIV以PaCO2目标正常化为滴定目标(条件性推荐,低确定性)。
关键数值与推荐
- 夜间NIV:条件性推荐,中等确定性。
- 启动前筛查阻塞性睡眠呼吸暂停:条件性推荐,极低确定性。
- 不在急性加重住院期间启动长期NIV,缓解后2-4周再评估:条件性推荐,低确定性。
- 不用实验室过夜多导睡眠图滴定NIV:条件性推荐,极低确定性。
- NIV以PaCO2目标正常化为滴定目标:条件性推荐,低确定性。
临床怎么用
- 对慢性稳定期高碳酸血症性慢阻肺患者,可考虑在常规治疗基础上加用夜间NIV。
- 启动长期NIV前应筛查阻塞性睡眠呼吸暂停。
- 急性加重住院期间不启动长期NIV,待缓解后2-4周再评估。
- 启动NIV时不必使用实验室过夜多导睡眠图滴定,可考虑以PaCO2正常化为目标进行滴定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Noninvasive ventilation (NIV) is used for patients with chronic obstructive pulmonary disease (COPD) and chronic hypercapnia. However, evidence for clinical efficacy and optimal management of therapy is limited.Target Audience: Patients with COPD, clinicians who care for them, and policy makers.Methods: We summarized evidence addressing five PICO (patients, intervention, comparator, and outcome) questions. The GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) approach was used to evaluate the certainty in evidence and generate actionable recommendations. Recommendations were formulated by a panel of pulmonary and sleep physicians, respiratory therapists, and methodologists using the Evidence-to-Decision framework.Recommendations:1) We suggest the use of nocturnal NIV in addition to usual care for patients with chronic stable hypercapnic COPD (conditional recommendation, moderate certainty); 2) we suggest that patients with chronic stable hypercapnic COPD undergo screening for obstructive sleep apnea before initiation of long-term NIV (conditional recommendation, very low certainty); 3) we suggest not initiating long-term NIV during an admission for acute-on-chronic hypercapnic respiratory failure, favoring instead reassessment for NIV at 2-4 weeks after resolution (conditional recommendation, low certainty); 4) we suggest not using an in-laboratory overnight polysomnogram to titrate NIV in patients with chronic stable hypercapnic COPD who are initiating NIV (conditional recommendation, very low certainty); and 5) we suggest NIV with targeted normalization of PaCO2 in patients with hypercapnic COPD on long-term NIV (conditional recommendation, low certainty).Conclusions: This expert panel provides evidence-based recommendations addressing the use of NIV in patients with COPD and chronic stable hypercapnic respiratory failure.
引用
- Macrea M, Oczkowski S, Rochwerg B, et al. Long-Term Noninvasive Ventilation in Chronic Stable Hypercapnic Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2020. PMID: 32795139. doi:10.1164/rccm.202006-2382ST
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。